Comparison Chart LB Pharmaceuticals Inc

Stocks

LBRX

US50180M1080

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-10-23 EDT			5-day change	1st Jan Change
38.73 ^USD	-1.75%		+5.42%	+73.99%

10-10	Lb Pharmaceuticals Inc Presents New Preclinical Data Supporting Lb-102?S Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs At 39Th Ecnp Congress	CI
10-09	Canaccord Genuity Initiates LB Pharmaceuticals at Buy With $65 Price Target	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	LB PHARMACEUTICALS INC	Bio Therapeutic Drugs	-1.75%	+5.42%	+73.99%	+144.51%	-	1.25B